Vaccines Market | Acumen Research and Consulting

CHAPTER 1. Industry Overview of Vaccines Market

1.1. Definition and Scope

1.1.1. Definition of Vaccines

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Vaccines Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Vaccines Market By Type

1.2.3. Vaccines Market By Age

1.2.4. Vaccines Market By Technology

1.2.5. Vaccines Market By Indication

1.2.6. Vaccines Market By Route of Administration

1.2.7. Vaccines Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Vaccines Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Vaccines Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

 

CHAPTER 5. Vaccines Market By Type

5.1. Introduction

5.2. Vaccines Revenue By Type

5.2.1. Vaccines Revenue (USD Million) and Forecast, By Type, 2020-2032

5.2.2. Monovalent

5.2.2.1. Monovalent Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Multivalent

5.2.3.1. Multivalent Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Vaccines Market By Age

6.1. Introduction

6.2. Vaccines Revenue By Age

6.2.1. Vaccines Revenue (USD Million) and Forecast, By Age, 2020-2032

6.2.2. Adult

6.2.2.1. Spectral Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Pediatric

6.2.3.1. Pediatric Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Vaccines Market By Technology

7.1. Introduction

7.2. Vaccines Revenue By Technology

7.2.1. Vaccines Revenue (USD Million) and Forecast, By Technology, 2020-2032

7.2.2. Conjugate Vaccines

7.2.2.1. Conjugate Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Inactivated Vaccines

7.2.3.1. Inactivated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Live Attenuated Vaccines

7.2.4.1. Live Attenuated Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Toxoid Vaccines

7.2.5.1. Toxoid Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.6. Recombinant Vaccines

7.2.6.1. Recombinant Vaccines Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 8. Vaccines Market By Indication

8.1. Introduction

8.2. Vaccines Revenue By Indication

8.2.1. Vaccines Revenue (USD Million) and Forecast, By Indication, 2020-2032

8.2.2. Dengue

8.2.2.1. Dengue Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.3. DTP

8.2.3.1. DTP Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.4. Hepatitis

8.2.4.1. Hepatitis Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.5. HPV

8.2.5.1. HPV Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.6. Influenza

8.2.6.1. Influenza Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.7. Meningococcal

8.2.7.1. Meningococcal Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.8. MMR

8.2.8.1. MMR Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.9. Pneumococcal

8.2.9.1. Pneumococcal Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.10. Polio

8.2.10.1. Polio Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.11. Rotavirus

8.2.11.1. Rotavirus Market Revenue (USD Million) and Growth Rate (%), 2020-2032

8.2.12. Varicella

8.2.12.1. Varicella Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 9. Vaccines Market By Route of Administration

9.1. Introduction

9.2. Vaccines Revenue By Route of Administration

9.2.1. Vaccines Revenue (USD Million) and Forecast, By Route of Administration, 2020-2032

9.2.2. Intramuscular

9.2.2.1. Intramuscular Market Revenue (USD Million) and Growth Rate (%), 2020-2032

9.2.3. Subcutaneous

9.2.3.1. Subcutaneous Market Revenue (USD Million) and Growth Rate (%), 2020-2032

9.2.4. Oral

9.2.4.1. Oral Market Revenue (USD Million) and Growth Rate (%), 2020-2032

9.2.5. Others

9.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 10. North America Vaccines Market By Country 

10.1. North America Vaccines Market Overview

10.2. U.S.

10.2.1. U.S. Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

10.2.2. U.S. Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

10.2.3. U.S. Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

10.2.4. U.S. Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

10.2.5. U.S. Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

10.3. Canada

10.3.1. Canada Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

10.3.2. Canada Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

10.3.3. Canada Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

10.3.4. Canada Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

10.3.5. Canada Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

10.4. North America PEST Analysis

 

CHAPTER 11. Europe Vaccines Market By Country

11.1. Europe Vaccines Market Overview

11.2. U.K.

11.2.1. U.K. Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

11.2.2. U.K. Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

11.2.3. U.K. Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

11.2.4. U.K. Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

11.2.5. U.K. Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

11.3. Germany

11.3.1. Germany Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

11.3.2. Germany Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

11.3.3. Germany Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

11.3.4. Germany Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

11.3.5. Germany Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

11.4. France

11.4.1. France Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

11.4.2. France Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

11.4.3. France Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

11.4.4. France Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

11.4.5. France Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

11.5. Spain

11.5.1. Spain Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

11.5.2. Spain Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

11.5.3. Spain Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

11.5.4. Spain Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

11.5.5. Spain Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

11.6. Rest of Europe

11.6.1. Rest of Europe Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

11.6.2. Rest of Europe Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

11.6.3. Rest of Europe Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

11.6.4. Rest of Europe Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

11.6.5. Rest of Europe Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

11.7. Europe PEST Analysis

 

CHAPTER 12. Asia Pacific Vaccines Market By Country

12.1. Asia Pacific Vaccines Market Overview

12.2. China

12.2.1. China Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.2.2. China Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.2.3. China Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.2.4. China Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.2.5. China Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.3. Japan

12.3.1. Japan Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.3.2. Japan Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.3.3. Japan Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.3.4. Japan Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.3.5. Japan Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.4. India

12.4.1. India Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.4.2. India Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.4.3. India Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.4.4. India Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.4.5. India Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.5. Australia

12.5.1. Australia Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.5.2. Australia Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.5.3. Australia Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.5.4. Australia Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.5.5. Australia Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.6. South Korea

12.6.1. South Korea Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.6.2. South Korea Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.6.3. South Korea Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.6.4. South Korea Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.6.5. South Korea Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.7. Rest of Asia-Pacific

12.7.1. Rest of Asia-Pacific Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

12.7.2. Rest of Asia-Pacific Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

12.7.3. Rest of Asia-Pacific Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

12.7.4. Rest of Asia-Pacific Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

12.7.5. Rest of Asia-Pacific Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

12.8. Asia Pacific PEST Analysis

 

CHAPTER 13. Latin America Vaccines Market By Country

13.1. Latin America Vaccines Market Overview

13.2. Brazil

13.2.1. Brazil Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

13.2.2. Brazil Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

13.2.3. Brazil Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

13.2.4. Brazil Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

13.2.5. Brazil Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

13.3. Mexico

13.3.1. Mexico Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

13.3.2. Mexico Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

13.3.3. Mexico Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

13.3.4. Mexico Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

13.3.5. Mexico Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

13.4. Rest of Latin America

13.4.1. Rest of Latin America Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

13.4.2. Rest of Latin America Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

13.4.3. Rest of Latin America Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

13.4.4. Rest of Latin America Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

13.4.5. Rest of Latin America Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

13.5. Latin America PEST Analysis

 

CHAPTER 14. Middle East & Africa Vaccines Market By Country 

14.1. Middle East & Africa Vaccines Market Overview

14.2. GCC

14.2.1. GCC Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

14.2.2. GCC Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

14.2.3. GCC Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

14.2.4. GCC Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

14.2.5. GCC Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

14.3. South Africa

14.3.1. South Africa Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

14.3.2. South Africa Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

14.3.3. South Africa Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

14.3.4. South Africa Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

14.3.5. South Africa Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

14.4. Rest of Middle East & Africa

14.4.1. Rest of Middle East & Africa Vaccines Revenue (USD Million) and Forecast By Age, 2020-2032

14.4.2. Rest of Middle East & Africa Vaccines Revenue (USD Million) and Forecast By Type, 2020-2032

14.4.3. Rest of Middle East & Africa Vaccines Revenue (USD Million) and Forecast By Technology, 2020-2032

14.4.4. Rest of Middle East & Africa Vaccines Revenue (USD Million) and Forecast By Indication, 2020-2032

14.4.5. Rest of Middle East & Africa Vaccines Revenue (USD Million) and Forecast By Route of Administration, 2020-2032

14.5. Middle East & Africa PEST Analysis

 

CHAPTER 15. Player Analysis Of Vaccines Market

15.1. Vaccines Market Company Share Analysis

15.2. Competition Matrix

15.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

15.2.2. New Product Launches and Product Enhancements

15.2.3. Mergers And Acquisition In Global Vaccines Market

15.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 16. Company Profile

16.1. Sinovac

16.1.1. Company Snapshot

16.1.2. Business Overview

16.1.3. Financial Overview

16.1.3.1. Revenue (USD Million), 2023

16.1.3.2. Sinovac 2023 Vaccines Business Regional Distribution

16.1.4. Product /Service and Specification

16.1.5. Recent Developments & Business Strategy

16.2. GSK Plc.

16.3. Seqirus

16.4. BioNTech SE

16.5. Pfizer Inc.

16.6. Sanofi

16.7. Serum Institute of India Pvt. Ltd.

16.8. AstraZeneca

16.9. Moderna Inc.

16.10. Merck & Co., Inc.